Financhill
Buy
58

RSPH Quote, Financials, Valuation and Earnings

Last price:
$28.85
Seasonality move :
0.99%
Day range:
$28.93 - $29.29
52-week range:
$26.36 - $32.85
Dividend yield:
0.77%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
67.4K
Avg. volume:
97.8K
1-year change:
-4.41%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- -- -- -- --
FBT
First Trust NYSE Arca Biotechnology Index Fund
-- -- -- -- --
PBE
Invesco Biotechnology & Genome ETF
-- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- --
XBI
SPDR S&P Biotech ETF
-- -- -- -- --
XLV
Health Care Select Sector SPDR Fund
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
$29.02 -- -- -- $0.06 0.77% --
FBT
First Trust NYSE Arca Biotechnology Index Fund
$166.58 -- -- -- $1.17 0.7% --
PBE
Invesco Biotechnology & Genome ETF
$66.14 -- -- -- $0.13 0.25% --
PJP
Invesco Pharmaceuticals ETF
$82.48 -- -- -- $0.27 1.17% --
XBI
SPDR S&P Biotech ETF
$87.02 -- -- -- $0.01 0.04% --
XLV
Health Care Select Sector SPDR Fund
$135.19 -- -- -- $0.63 1.77% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- 0.851 -- --
FBT
First Trust NYSE Arca Biotechnology Index Fund
-- 0.653 -- --
PBE
Invesco Biotechnology & Genome ETF
-- 0.915 -- --
PJP
Invesco Pharmaceuticals ETF
-- 0.248 -- --
XBI
SPDR S&P Biotech ETF
-- 1.018 -- --
XLV
Health Care Select Sector SPDR Fund
-- 0.461 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
-- -- -- -- -- --
FBT
First Trust NYSE Arca Biotechnology Index Fund
-- -- -- -- -- --
PBE
Invesco Biotechnology & Genome ETF
-- -- -- -- -- --
PJP
Invesco Pharmaceuticals ETF
-- -- -- -- -- --
XBI
SPDR S&P Biotech ETF
-- -- -- -- -- --
XLV
Health Care Select Sector SPDR Fund
-- -- -- -- -- --

Invesco S&P 500 Eql Wght Health Care ETF vs. Competitors

  • Which has Higher Returns RSPH or FBT?

    First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- --
    FBT
    First Trust NYSE Arca Biotechnology Index Fund
    -- -- --
  • What do Analysts Say About RSPH or FBT?

    Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.

    Company Buy Ratings Hold Ratings Sell Ratings
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    0 0 0
    FBT
    First Trust NYSE Arca Biotechnology Index Fund
    0 0 0
  • Is RSPH or FBT More Risky?

    Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.641, suggesting its less volatile than the S&P 500 by 35.874%.

  • Which is a Better Dividend Stock RSPH or FBT?

    Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.77%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.7% to investors and pays a quarterly dividend of $1.17 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RSPH or FBT?

    Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- -- --
    FBT
    First Trust NYSE Arca Biotechnology Index Fund
    -- -- -- --
  • Which has Higher Returns RSPH or PBE?

    Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- --
    PBE
    Invesco Biotechnology & Genome ETF
    -- -- --
  • What do Analysts Say About RSPH or PBE?

    Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Biotechnology & Genome ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    0 0 0
    PBE
    Invesco Biotechnology & Genome ETF
    0 0 0
  • Is RSPH or PBE More Risky?

    Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.810, suggesting its less volatile than the S&P 500 by 19.007%.

  • Which is a Better Dividend Stock RSPH or PBE?

    Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.77%. Invesco Biotechnology & Genome ETF offers a yield of 0.25% to investors and pays a quarterly dividend of $0.13 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RSPH or PBE?

    Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- -- --
    PBE
    Invesco Biotechnology & Genome ETF
    -- -- -- --
  • Which has Higher Returns RSPH or PJP?

    Invesco Pharmaceuticals ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- --
  • What do Analysts Say About RSPH or PJP?

    Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Invesco Pharmaceuticals ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    0 0 0
    PJP
    Invesco Pharmaceuticals ETF
    0 0 0
  • Is RSPH or PJP More Risky?

    Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.771%.

  • Which is a Better Dividend Stock RSPH or PJP?

    Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.77%. Invesco Pharmaceuticals ETF offers a yield of 1.17% to investors and pays a quarterly dividend of $0.27 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RSPH or PJP?

    Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- -- --
    PJP
    Invesco Pharmaceuticals ETF
    -- -- -- --
  • Which has Higher Returns RSPH or XBI?

    SPDR S&P Biotech ETF has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- --
    XBI
    SPDR S&P Biotech ETF
    -- -- --
  • What do Analysts Say About RSPH or XBI?

    Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than SPDR S&P Biotech ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    0 0 0
    XBI
    SPDR S&P Biotech ETF
    0 0 0
  • Is RSPH or XBI More Risky?

    Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.917, suggesting its less volatile than the S&P 500 by 8.345%.

  • Which is a Better Dividend Stock RSPH or XBI?

    Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.77%. SPDR S&P Biotech ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.01 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RSPH or XBI?

    Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- -- --
    XBI
    SPDR S&P Biotech ETF
    -- -- -- --
  • Which has Higher Returns RSPH or XLV?

    Health Care Select Sector SPDR Fund has a net margin of -- compared to Invesco S&P 500 Eql Wght Health Care ETF's net margin of --. Invesco S&P 500 Eql Wght Health Care ETF's return on equity of -- beat Health Care Select Sector SPDR Fund's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- --
    XLV
    Health Care Select Sector SPDR Fund
    -- -- --
  • What do Analysts Say About RSPH or XLV?

    Invesco S&P 500 Eql Wght Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Health Care Select Sector SPDR Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P 500 Eql Wght Health Care ETF has higher upside potential than Health Care Select Sector SPDR Fund, analysts believe Invesco S&P 500 Eql Wght Health Care ETF is more attractive than Health Care Select Sector SPDR Fund.

    Company Buy Ratings Hold Ratings Sell Ratings
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    0 0 0
    XLV
    Health Care Select Sector SPDR Fund
    0 0 0
  • Is RSPH or XLV More Risky?

    Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, which suggesting that the stock is 11.971% less volatile than S&P 500. In comparison Health Care Select Sector SPDR Fund has a beta of 0.657, suggesting its less volatile than the S&P 500 by 34.272%.

  • Which is a Better Dividend Stock RSPH or XLV?

    Invesco S&P 500 Eql Wght Health Care ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.77%. Health Care Select Sector SPDR Fund offers a yield of 1.77% to investors and pays a quarterly dividend of $0.63 per share. Invesco S&P 500 Eql Wght Health Care ETF pays -- of its earnings as a dividend. Health Care Select Sector SPDR Fund pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios RSPH or XLV?

    Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues are --, which are smaller than Health Care Select Sector SPDR Fund quarterly revenues of --. Invesco S&P 500 Eql Wght Health Care ETF's net income of -- is lower than Health Care Select Sector SPDR Fund's net income of --. Notably, Invesco S&P 500 Eql Wght Health Care ETF's price-to-earnings ratio is -- while Health Care Select Sector SPDR Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P 500 Eql Wght Health Care ETF is -- versus -- for Health Care Select Sector SPDR Fund. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    RSPH
    Invesco S&P 500 Eql Wght Health Care ETF
    -- -- -- --
    XLV
    Health Care Select Sector SPDR Fund
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 1.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock